ASHLEY CHAMPLIN: Open Payments
NPI 1407449838 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 17 payments from 8 companies in 2025. Trend: 2023 $287 · 2024 $532 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $361 |
| Novartis Pharmaceuticals Corporation | 6 | $169 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Novo Nordisk Inc | 1 | $29 |
| AngioDynamics, Inc. | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $16 |
| Amgen Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: WAINUA, LEQVIO, LOKELMA, Wegovy, ELIQUIS, CAMZYOS, ANGIOVAC, LifeVest.
Industry payments across NM — which companies pay providers there.
